Pedro Herranz

5.3k total citations
141 papers, 1.7k citations indexed

About

Pedro Herranz is a scholar working on Dermatology, Epidemiology and Immunology. According to data from OpenAlex, Pedro Herranz has authored 141 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Dermatology, 41 papers in Epidemiology and 36 papers in Immunology. Recurrent topics in Pedro Herranz's work include Dermatology and Skin Diseases (39 papers), Psoriasis: Treatment and Pathogenesis (28 papers) and Allergic Rhinitis and Sensitization (18 papers). Pedro Herranz is often cited by papers focused on Dermatology and Skin Diseases (39 papers), Psoriasis: Treatment and Pathogenesis (28 papers) and Allergic Rhinitis and Sensitization (18 papers). Pedro Herranz collaborates with scholars based in Spain, United States and Italy. Pedro Herranz's co-authors include Marta Feito Rodríguez, Elena Sendagorta, Mariano Casado, Rosario Cabañas, Teresa Bellón, Elena Ramı́rez, Matías Mayor, Ana Fiandor, J.L. López‐Estebaranz and Antonia Expósito and has published in prestigious journals such as Journal of the American Academy of Dermatology, AIDS and British Journal of Dermatology.

In The Last Decade

Pedro Herranz

133 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pedro Herranz Spain 23 711 442 310 264 244 141 1.7k
Vicente García‐Patos Spain 23 602 0.8× 741 1.7× 403 1.3× 419 1.6× 297 1.2× 124 2.0k
Claudio Guarneri Italy 26 558 0.8× 296 0.7× 684 2.2× 286 1.1× 287 1.2× 128 1.9k
Miriam Keltz Pomeranz United States 19 422 0.6× 272 0.6× 170 0.5× 235 0.9× 225 0.9× 95 1.4k
Neil Cox United Kingdom 15 549 0.8× 361 0.8× 148 0.5× 167 0.6× 127 0.5× 50 1.4k
M.‐S. Doutre France 20 405 0.6× 317 0.7× 203 0.7× 479 1.8× 114 0.5× 131 1.4k
David R. Berk United States 23 562 0.8× 277 0.6× 210 0.7× 137 0.5× 260 1.1× 109 1.6k
Alex Richter United Kingdom 25 156 0.2× 256 0.6× 367 1.2× 118 0.4× 325 1.3× 103 2.2k
Tarun Narang India 21 508 0.7× 747 1.7× 213 0.7× 121 0.5× 333 1.4× 184 1.9k
J.L. López‐Estebaranz Spain 27 1.5k 2.1× 375 0.8× 974 3.1× 246 0.9× 129 0.5× 143 2.5k
Shinichi Imafuku Japan 25 1.2k 1.7× 394 0.9× 1.2k 4.0× 464 1.8× 67 0.3× 182 2.3k

Countries citing papers authored by Pedro Herranz

Since Specialization
Citations

This map shows the geographic impact of Pedro Herranz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Herranz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Herranz more than expected).

Fields of papers citing papers by Pedro Herranz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro Herranz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Herranz. The network helps show where Pedro Herranz may publish in the future.

Co-authorship network of co-authors of Pedro Herranz

This figure shows the co-authorship network connecting the top 25 collaborators of Pedro Herranz. A scholar is included among the top collaborators of Pedro Herranz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro Herranz. Pedro Herranz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dobao, P. de la Cueva, et al.. (2025). Patient Burden And Impact Of Moderate-to-Severe Atopic Dermatitis In the Spanish Healthcare System: The APOLO Cross-Sectional Study. Dermatology Practical & Conceptual. 15(3). 5538–5538. 1 indexed citations
2.
Frutos, F.J. Ortiz de, E. Serra‐Baldrich, J.C. Armario-Hita, et al.. (2024). [Translated article] Consensus on the Diagnostic Algorithm for Chronic Nodular Prurigo. Actas Dermo-Sifiliográficas. 115(10). T967–T973. 1 indexed citations
3.
Herranz, Pedro, et al.. (2024). Efficacy and Safety of Topical Roflumilast for the Treatment of Psoriasis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Clinical Drug Investigation. 44(9). 655–665. 2 indexed citations
4.
Ruíz‐Villaverde, Ricardo, et al.. (2024). Carga clínica, psicosocial y económica de la dermatitis atópica en vida real: resultados de la cohorte española del estudio MEASURE-AD. Actas Dermo-Sifiliográficas. 116(1). 5–14. 1 indexed citations
5.
6.
Hita, José Carlos Armario, J.M. Carrascosa, Ángeles Flórez, et al.. (2023). Pruritus and Pain Constitute the Main Negative Impact of Atopic Dermatitis® from the Patient's Perspective: A Systematic Review. Dermatitis. 35(3). 216–234. 1 indexed citations
7.
Sahuquillo‐Torralba, Antonio, Mar Llamas‐Velasco, R. Rivera, et al.. (2023). Effectiveness and safety of brodalumab in the treatment of plaque, scalp and palmoplantar psoriasis: A multicentre retrospective study in a Spanish population. Australasian Journal of Dermatology. 64(4). e317–e326. 3 indexed citations
8.
Paul, C., C.E.M. Griffiths, Antonio Costanzo, et al.. (2023). Factors Predicting Quality of Life Impairment in Adult Patients with Atopic Dermatitis: Results from a Patient Survey and Machine Learning Analysis. Dermatology and Therapy. 13(4). 981–995. 8 indexed citations
9.
Bernardino, José Ignacio, et al.. (2022). Human monkeypox outbreak: Epidemiological data and therapeutic potential of topical cidofovir in a prospective cohort study. Journal of the American Academy of Dermatology. 88(5). 1074–1082. 27 indexed citations
10.
Rodríguez, J, Pedro Herranz, Bibiana Pérez, et al.. (2022). Upadacitinib for the Treatment of Atopic Dermatitis in a Spanish Cohort—Real Life: Fifty-Two–Week Follow-up Results. Dermatitis. 33(6S). S124–S127. 8 indexed citations
11.
Yosipovitch, Gil, Marjolein de Bruin‐Weller, April W. Armstrong, et al.. (2021). Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis. Dermatology and Therapy. 11(6). 2147–2157. 7 indexed citations
12.
Herranz, Pedro, et al.. (2021). Ibrutinib‐induced leg ulcer successfully treated with platelet‐rich plasma. Dermatologic Therapy. 34(2). e14874–e14874.
13.
Busca, Carmen, et al.. (2021). Psoriasis and Liver Damage in HIV-Infected Patients. Cells. 10(5). 1099–1099. 2 indexed citations
14.
Balas, A., Elena Ramı́rez, Elena Trigo, et al.. (2020). HLA-A∗68, -A∗11:01, and -A∗29:02 alleles are strongly associated with benznidazole-induced maculopapular exanthema (MPE)/DRESS. The Journal of Allergy and Clinical Immunology In Practice. 8(9). 3198–3200.e3. 10 indexed citations
15.
16.
Zozaya, Néboa, José Carlos Armario Hita, J.M. Carrascosa, et al.. (2018). Determining the Value of Two Biologic Drugs for Chronic Inflammatory Skin Diseases: Results of a Multi-Criteria Decision Analysis. BioDrugs. 32(3). 281–291. 20 indexed citations
17.
Moreno-Ramos, Francisco, et al.. (2015). Anti-tnf dose and anti-drug antibody levels in rheumatic and psoriasis patients: Economic repercussion. 17(2). 4. 3 indexed citations
18.
Redaelli, Alessio, et al.. (2014). European expert recommendations on the use of injectable poly-L-lactic acid for facial rejuvenation.. PubMed. 13(9). 1057–66. 32 indexed citations
19.
Gómez‐Fernández, Cristina, et al.. (2014). Diffuse Reactive Angioendotheliomatosis Secondary to the Administration of Trabectedin and Pegfilgrastim. American Journal of Dermatopathology. 37(7). 581–584. 5 indexed citations
20.
Herranz, Pedro, et al.. (2004). Revisión de la Zona de Ossa Morena y de sus límites. Consecuencias para la definición de la Zona Lusitano-Mariánica. Complutensian Scientific Journals (Complutense University of Madrid). 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vicente García‐Patos Breakdown of academic impact, for papers by Claudio Guarneri Breakdown of academic impact, for papers by Miriam Keltz Pomeranz Breakdown of academic impact, for papers by Neil Cox Breakdown of academic impact, for papers by M.‐S. Doutre Breakdown of academic impact, for papers by David R. Berk Breakdown of academic impact, for papers by Alex Richter Breakdown of academic impact, for papers by Tarun Narang Breakdown of academic impact, for papers by J.L. López‐Estebaranz Breakdown of academic impact, for papers by Shinichi Imafuku
Rankless by CCL
2026